The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

18 May 2016 07:00

RNS Number : 5314Y
Ideagen PLC
18 May 2016
 

18 May 2016

 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

 

Pre-Close Trading Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, is pleased to provide an update on trading for the year ended 30 April 2016 ahead of the announcement of its full year results.

 

The Board is pleased to report that trading for the year was robust and results to 30 April 2016 are expected to be in line with market expectations. The Group delivered strong organic revenue growth of 10 per cent., and a full year contribution from Gael which was acquired in January 2015.

 

The Group expects to report revenue of approximately £21.9 million (FY2015: £14.4 million), an increase of 52 per cent. resulting in adjusted EBITDA* of approximately £6.3 million (FY2015: £4.0 million), an increase of 57 per cent. This represents the Group's seventh consecutive year of revenue and EBITDA* growth. In addition, the Group expects to show a significant increase in adjusted EPS** which continues to be an important financial metric for the Group.

 

Cash generation remained strong, particularly in the second half of the year, and net cash at 30 April 2016 was £6.3 million (31 October 2015: £5.4 million), after paying £1.7 million of deferred consideration, principally for the Gael acquisition, and £0.3 million in dividends. The Group continues to maintain a debt-free balance sheet.

 

The strong trading results have been driven predominately by healthy demand across the Group's Governance, Risk and Compliance ("GRC") markets, including the manufacturing, life sciences, aviation and rail verticals. The Board is also encouraged by the success of the Group's newly launched SaaS platform, Enlighten, which is allowing the Group to win larger contracts and grow high visibility, subscription-based revenue. As a result, the Board remains confident in the long term growth prospects for the Group.

 

David Hornsby, Chief Executive, commented: "The Group has once again delivered another year of high quality earnings growth, demonstrating the strength of our business model, the quality of our products and the talent of our employees. The Group has significant contracted work in progress, a growing recurring revenue base and a healthy pipeline of new business, which leaves me optimistic about the continued growth opportunities for the Group."

 

*Earnings before interest, tax, depreciation, amortisation, share based payments, acquisition costs and exceptional items.

**Adjusted diluted earnings per share

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Stuart Andrews/James Thompson (Nomad)

 

Stephen Norcross (Corporate Broking)

 

 

 

Alma PR

 

Hilary Buchanan

+44 (0)7515 805218

Josh Royston

+44 (0)7780 901979

 

 

About Ideagen Group plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L). Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in eGRC (Enterprise Governance, Risk and Compliance) and Healthcare solutions for organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete content lifecycle solutions that enable organisations to meet their Regulatory and Quality Compliance standards, helping them to reduce costs and improve efficiency.

 

The Group has a customer base of over 2,200 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDDLFFQEFZBBD
Date   Source Headline
1st Jun 202211:45 amRNSForm 8.5 (EPT/RI)
1st Jun 202211:04 amRNSForm 8.3 - Ideagen plc
1st Jun 202211:00 amRNSForm 8.3 - Ideagen Plc
1st Jun 202210:20 amRNSForm 8.3 - IDEAGEN PLC
1st Jun 202210:17 amGNWForm 8.3 - Ideagen PLC
31st May 20223:29 pmRNSForm 8.5 (EPT/RI)- Amendment
31st May 20223:15 pmBUSForm 8.3 - Ideagen plc
31st May 20223:03 pmRNSForm 8.3 - Ideagen plc
31st May 202212:12 pmRNSForm 8.3 - Ideagen plc
31st May 202211:10 amRNSForm 8.5 (EPT/RI)
31st May 202211:04 amBUSForm 8.3 - IDEAGEN PLC
31st May 20229:59 amRNSForm 8.3 - Ideagen plc
31st May 20229:55 amGNWForm 8.3 - Ideagen PLC
30th May 20224:45 pmRNSDirector/PDMR Shareholding
30th May 20224:01 pmBUSForm 8.3 - Ideagen plc
30th May 20223:30 pmRNSHolding(s) in Company
30th May 20223:00 pmBUSForm 8.3 - IDEA LN
30th May 20222:47 pmRNSForm 8.3 - Ideagen Plc
30th May 20221:01 pmGNWForm 8.3 - [Ideagen plc - 27 05 2022] - (CGWL)
30th May 202212:29 pmRNSForm 8.3 - Ideagen plc
30th May 202212:16 pmGNWForm 8.3 - Ideagen PLC
30th May 202212:09 pmRNSForm 8.3 - Ideagen plc
30th May 202211:15 amRNSPublication of Scheme Document
30th May 202211:09 amRNSForm 8.5 (EPT/RI)
30th May 202211:02 amRNSForm 8.5 (EPT/RI)
30th May 202210:29 amGNWForm 8.3 - Ideagen Plc
30th May 202210:04 amRNSForm 8.3 - Ideagen PLC
30th May 20227:07 amRNSForm 8.5 (EPT/RI) - Amendment
27th May 20223:20 pmRNSForm 8.3 - Ideagen plc
27th May 20223:15 pmBUSForm 8.3 - Ideagen plc
27th May 20222:35 pmRNSForm 8.3 - Ideagen PLC
27th May 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
27th May 202212:15 pmRNSForm 8.3 - Ideagen plc
27th May 202211:59 amGNWForm 8.3 - [IDEAGEN PLC - 26 05 2022] - CGWL
27th May 202211:43 amRNSForm 8.3 - Ideagen plc
27th May 202211:34 amRNSForm 8.5 (EPT/RI)
27th May 202210:43 amRNSForm 8.3 - Ideagen plc
27th May 202210:42 amGNWForm 8.3 - Ideagen PLC
27th May 202210:00 amGNWForm 8.3 - Ideagen PLC
26th May 20223:20 pmRNSForm 8.3 - Ideagen plc
26th May 20223:15 pmBUSForm 8.3 - Ideagen plc
26th May 20221:15 pmRNSForm 8.3 - Ideagen plc
26th May 202212:29 pmRNSForm 8.3 - Ideagen plc
26th May 202212:10 pmGNWForm 8.3 - [IDEAGEN PLC - 25 05 2022] - CGWL
26th May 202211:38 amRNSForm 8.3 - Ideagen Plc
26th May 202211:06 amRNSForm 8.5 (EPT/RI)
26th May 202210:49 amGNWForm 8.3 - Ideagen PLC
26th May 202210:31 amRNSRule 2.9 Announcement
26th May 202210:30 amRNSIssue of Equity and TVR
26th May 20229:57 amRNSForm 8.3 - Ideagen Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.